Drugs / SPD422
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03866434 | Feb → Apr 2019 | — | Shire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPD422 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03866434 ↗ |
| Route | Oral | “capsule orally on Day 1 and 8” NCT03866434 ↗ |